Vertex Pharmaceuticals
VRTX
#173
Rank
NZ$206.32 B
Marketcap
NZ$804.73
Share price
4.17%
Change (1 day)
-5.09%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): NZ$7.67 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$11.72 Billion. In 2024 the company made an earning of NZ$0.46 Billion a decrease over its 2023 earnings that were of NZ$7.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$7.67 B1532.51%
2024 NZ$0.46 B-93.69%
2023 NZ$7.44 B3.19%
2022 NZ$7.21 B53.56%
2021 NZ$4.70 B-12.06%
2020 NZ$5.34 B118.45%
2019 NZ$2.44 B120.64%
2018 NZ$1.10 B1473.64%
2017 NZ$70.48 M197.6%
2016 NZ$23.68 M-102.97%
2015 -NZ$0.8 Billion-28.46%
2014 -NZ$1.12 Billion-51.5%
2013 -NZ$2.3 Billion-30584.68%
2012 NZ$7.54 M-95.47%
2011 NZ$0.16 B
2009 -NZ$1 Billion
2007 -NZ$0.7 Billion83.1%
2006 -NZ$0.38 Billion59.02%
2005 -NZ$0.24 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.38 Billion
2000 -NZ$64.06 Million-20.38%
1999 -NZ$80.45 Million31.62%
1998 -NZ$61.13 Million91.05%
1997 -NZ$32 Million-36.24%
1996 -NZ$50.18 Million12.45%
1995 -NZ$44.63 Million27.4%
1994 -NZ$35.03 Million-1833.33%
1993 NZ$2.02 M-112.12%
1992 -NZ$16.67 Million175%
1991 -NZ$6.07 Million-12.2%
1990 -NZ$6.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.54 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.79 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.64 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.87 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.52 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$0.13 Billion-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA